Vericel Corp — Director's Dealing 2012

Jun 27, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2012-06-25

Reporting Person: Watling Sharon (VP Clinical Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-25	Stock Option (right to buy)	$2.26	D	151937	Acquired	2012-06-25	Common Stock (151937)	Direct
2012-06-25	Stock Option (right to buy)	$2.26	A	151937	Acquired	2022-06-25	Common Stock (151937)	Direct

Footnotes

F1: On June 25, 2012, the unvested shares of an option granted to the reporting person on March 21, 2011 were cancelled. In exchange, the reporting person received a replacement option, granted on June 25, 2012, vesting in eleven equal quarterly installments commencing on September 21, 2012.